Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Small Cell Lung Carcinoma × camrelizumab × Clear all

Phase

Status

Sponsor Class

UNKNOWN 1 OTHER_GOV 1 OTHER 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Triple Negative Breast Neoplasms 2 Esophageal Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Advanced Gastric Adenocarcinoma 2 Solid Tumor 1 Small Cell Lung Carcinoma 1 Small Cell Lung Cancer Extensive Stage 1 Sarcoma 1 NSCLC 1 Mucosal Melanoma 1 Esophageal Squamous Cell Carcinoma 1 Esophageal Diseases 1 Drug-Related Side Effects and Adverse Reactions 1 Digestive System Neoplasms 1 Breast Neoplasms 1

Interventions

apatinib 4 Etoposide 3 surufatinib 2 Topotecan 2 Simvastatin 2 Irinotecan 2 Carboplatin 2 nintedanib 1 camrelizumab 1 anlotinib 1 Tomography, X-Ray Computed 1 Sunitinib 1 Sorafenib 1 Radiotherapy 1 Paclitaxel 1 PE regimen 1 Lithium 1 Immunotherapy 1 Ifosfamide 1 Gemcitabine 1 EC regimen 1 Drug Therapy 1 Cisplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04901754 2021-12-08

CAMERA

Henan Cancer Hospital

Phase 2 Unknown

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡